Ipsen Korea has appointed Yang Mi-sun, AstraZeneca Korea’s former Business Unit Director, as the new Chief Executive Officer (CEO).

Sources said that Ipsen Korea has appointed its new CEO, replacing former CEO Audrey Schweitzer after the end of her term. Audrey Schweitzer has been in charge of Ipsen Korea since 2021.

Yang is an industry specialist with extensive knowledge and 20 years of experience working in Korean and overseas pharmaceutical companies.

Yang obtained a degree from Chung-Ang University College of Pharmacy and has held positions for various medicines in South Korean and overseas pharmaceutical companies, including Samil-Pharm, Bayer, and MSD, since 2000.<